SDS Optic S.A.
SDS Optic S.A. operates in Biotechnology.
SDS Optic S.A. (SDS) - Net Assets
Latest net assets as of : zł- PLN
Based on the latest financial reports, SDS Optic S.A. (SDS) has net assets worth zł- PLN as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł-) and total liabilities (zł-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SDS Optic S.A. - Net Assets Trend (None–None)
This chart illustrates how SDS Optic S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SDS Optic S.A. (None–None)
The table below shows the annual net assets of SDS Optic S.A. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SDS Optic S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SDS Optic S.A. Competitors by Market Cap
The table below lists competitors of SDS Optic S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Acura Pharmaceuticals Inc
OTCQB:ACUR
|
$13.20K |
|
Record PLC
LSE:REC
|
$13.21K |
|
PAVmed Inc. Series Z Warrant
NASDAQ:PAVMZ
|
$13.21K |
|
Pum Yang Construction Co. Ltd.
KQ:002410
|
$13.21K |
|
ELEKTROIMPORTOREN NK -05
F:9F9
|
$13.17K |
|
Inflection Point Acquisition Corp. II Warrant
NASDAQ:IPXXW
|
$13.16K |
|
450050
KQ:450050
|
$13.16K |
|
Vinacontrol Group Corp
VN:VNC
|
$13.16K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SDS Optic S.A.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SDS Optic S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SDS Optic S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SDS Optic S.A.'s net assets metrics with peer companies in the Biotechnology & Medical Research industry.
Industry Context
- Industry: Biotechnology & Medical Research
- Average net assets among peers: $5,333,873
- Average return on equity (ROE) among peers: -2.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SDS Optic S.A. (SDS) | zł- | N/A | N/A | $13.18K |
| Readgene (RDG) | $3.24 Million | -2.36% | 3.67x | $12.88K |
| SCS (SCS) | $7.43 Million | -2.08% | 0.83x | $909.17 |